Replies to post #9295 on Momenta Pharmaceuticals, Inc. (MNTA)

[jmkobers]

The reason longs didn't sell in the mid 20's is simple. It's becasue their valuation model didn't have the shares as over-valued at that time!

And that is really the point of this valuation thread. It's hard for those who have followed this stock for a long time to embrace the current valuation model many longs are currently pushing, considering how wrong about it they have been over a long period. All things considered, it couldn't have been more flawed. The multiple risk factors that were always there were never fairly weighed, and it's highly likely that the current risk factors continue to be unrealistically discounted.

This should be pretty hard to argue at this point.

[io_io]

Why wouldn't one sell those shares when it hit $26+ in July 2010 after mEnox approval....I would be more impressed if one sold all of those shares above $25!

So I recalled that certain people did sell at the top - and I went back and found one such post - here - it was the insiders who reaped the benefits, dumping their stock onto the public.

You can see that it failed to deter board bravado, and there were many double-up type purchases posted upon the pop, including no less than three "adds" by DewD himself (note that I posted only the lowest of the three prices he claimed).